Thyroid mimetic as an option for lowering low-density lipoprotein

Proceedings of the National Academy of Sciences of the United States of America

Volumn 105, Issue 2, 2008, Pages 409-410

  Grundy, Scott M ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTILIPEMIC AGENT; DEXTROTHYROXINE; EZETIMIBE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; KB 2115; LOW DENSITY LIPOPROTEIN; THYROID HORMONE RECEPTOR; THYROXINE; UNCLASSIFIED DRUG;

ATHEROGENESIS; ATHEROSCLEROSIS; BILE ACID SYNTHESIS; BLOOD PRESSURE; CHOLESTEROL METABOLISM; COMBINATION CHEMOTHERAPY; DRUG BLOOD LEVEL; DRUG EFFECT; DRUG MECHANISM; ELECTROCARDIOGRAM; HEART RATE; HYPERCHOLESTEROLEMIA; HYPERTHYROIDISM; NONHUMAN; NOTE; PRIORITY JOURNAL; PROTEIN DEGRADATION; WEIGHT REDUCTION;

ANIMALS; CHOLESTEROL, LDL; HEART; HUMANS; LIPID METABOLISM; LIPOPROTEINS, LDL; LIVER; MODELS, BIOLOGICAL; MYOCARDIUM; PPAR GAMMA; PROTEIN ISOFORMS; RISK FACTORS; THIAZOLIDINEDIONES; THYROID GLAND;

EID: 38649083708     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.0705959104     Document Type: Note

References (20)

1. Berkenstam A, Kristensen J, Mellström K, Carlsson B, Malm J, Rehnmark S, Garg N, Andersson CM, Rudling M, Sjöberg F, et al. (2008) Proc Natl Acad Sci USA 105:663-667.
2. Grover GJ, Mellström K, Ye L, Malm J, Li YL, Bladh LG, Sleph PG, Smith MA, George R, Vennström B, et al. (2003) Proc Natl Acad Sci USA 100:10067-10072.
3. Grover GJ, Egan DM, Sleph PG, Beehler BC, Chiellini G, Nguyen NH, Baxter JD, Scanlan TS (2004) Endocrinology 145:1656-1661.
4. Salter AM, Hayashi R, al-Seeni M, Brown NF, Bruce J, Sorensen O, Atkinson EA, Middleton B, Bleackley RC, Brindley DN (1991) Biochem J 276:825-832.
5. Endo A (1992) J Lipid Res 33:1569-1582.
6. National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) (2002) Circulation 106:3143-3421.
7. Grundy SM, Cleeman JI, Merz CN, Brewer HB, Jr, Clark LT, Hunninghake DB, Pasternak RC, Smith SC, Jr, Stone NJ. National Heart, Lung, and Blood Institute, American College of Cardiology Foundation, American Heart Association (2004) Circulation 110:227-239.
8. LaRosa JC, Grundy SM, Waters DD, Shear C, Barter P, Fruchart JC, Gotto AM, Greten H, Kastelein JJ, Shepherd J, Wenger NK, Treating to New Targets (TNT) Investigators (2005) N Engl J Med 352:1425-1435.
9. Pedersen TR, Faergeman O, Kastelein JJ, Olsson AG, Tikkanen MJ, Holme I, Larsen ML, Bendiksen FS, Lindahl C, Szarek M, Tsai J (2005) J Am Med Assoc 294:2437-2445.
10. Baigent C, Keech A, Kearney PM, Blackwell L, Buck G, Pollicino C, Kirby A, Sourjina T, Peto R, Collins R, Simes R, Cholesterol Treatment Trialists' (CTT) Collaborators (2005) Lancet 366:1267-1278.
11. Grundy SM, Wilhelmsen L, Rose G, Campbell RW, Assman G (1990) Eur Heart J 11:462-471.
12. Cohen JC, Boerwinkle E, Mosley TH, Jr, Hobbs HH (2006) N Engl J Med 354:1264-1272.
13. Ma PTS, Gil G, Südhof TC, Bilheimer DW, Goldstein JL, Brown MS (1986) Proc Natl Acad Sci USA 83:8370-8374.
14. Pasternak RC, Smith SC, Jr, Bairey-Merz CN, Grundy SM, Cleeman JI, Lenfant C, American College of Cardiology, American Heart Association, National Heart, Lung, and Blood Institute (2002) Circulation 106:1024-1028.
15. Bays HE, Ose L, Fraser N, Tribble DL, Quinto K, Reyes R, Johnson-Levonas AO, Sapre A, Donahue SR, Ezetimibe Study Group (2004) Clin Ther 26:1758-1773.
16. Horton JD, Cohen JC, Hobbs HH (2007) Trends Biochem Sci 32:71-77.
17. Stamler J (1977) Adv Exp Med Biol 82:52-75.
18. Grundy SM, Ahrens EH, Jr, Salen G, Schreibman PH, Nestel PJ (1972) J Lipid Res 13:531-551.
19. Duncan JG, Fong JL, Medeiros DM, Finck BN, Kelly DP (2007) Circulation 115:909-917.
20. Bookout AL, Jeong Y, Downes M, Yu RT, Evans RM, Mangelsdorf DJ (2006) Cell 126:789-799.